Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

[Mid gut neuroendocrine tumors: News on medical treatment].

Dior M, Dreanic J, Prieux-Klotz C, Brieau B, Brezault C, Coriat R.

Presse Med. 2017 Jan;46(1):4-10. doi: 10.1016/j.lpm.2016.09.001. Epub 2017 Jan 11. Review. French.

PMID:
28089247
2.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group..

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

PMID:
27995656
3.

Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment.

Voican CS, Mir O, Loulergue P, Dhooge M, Brezault C, Dréanic J, Chaussade S, Pol S, Coriat R.

Ann Oncol. 2016 Dec;27(12):2172-2184. doi: 10.1093/annonc/mdw414. Epub 2016 Nov 1. Review.

PMID:
27803003
4.

Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib.

Moryoussef F, Dhooge M, Volet J, Barbe C, Brezault C, Hoeffel C, Coriat R, Bouché O.

J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):343-50. doi: 10.1002/jcsm.12047. Epub 2015 Jun 4.

5.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group..

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

PMID:
26549003
6.

Resection of Late Pulmonary Metastases from Pancreatic Adenocarcinoma: Is Surgery an Option?

Brieau B, Barret M, Rouquette A, Dréanic J, Brezault C, Regnard JF, Coriat R.

Cancer Invest. 2015;33(10):522-5. doi: 10.3109/07357907.2015.1080831. Epub 2015 Oct 13.

PMID:
26461032
7.

Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients.

Dréanic J, Dhooge M, Barret M, Brezault C, Mir O, Chaussade S, Coriat R.

J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):231-6. doi: 10.1002/jcsm.12022. Epub 2015 May 5.

8.

Long term exposure to antiangiogenic therapy, bevacizumab, induces osteonecrosis.

Tabouret T, Gregory T, Dhooge M, Brezault C, Mir O, Dréanic J, Chaussade S, Coriat R.

Invest New Drugs. 2015 Oct;33(5):1144-7. doi: 10.1007/s10637-015-0283-x. Epub 2015 Aug 28.

PMID:
26311072
9.

Gastric Carcinoma at the Era of Targeted Therapies.

Dreanic J, Dhooge M, Sion E, Brezault C, Chaussade S, Coriat R.

Curr Drug Targets. 2016;17(15):1818-1826.

PMID:
25944013
10.

Incidence of organizing pneumonia induced by oxaliplatin chemotherapy for digestive cancer.

Bellanger C, Dhooge M, Tabouret T, Chapron J, Dreanic J, Brezault C, Goldwasser F, Dusser D, Chaussade S, Coriat R.

Ann Pharmacother. 2015 Apr;49(4):494-5. doi: 10.1177/1060028015569595. Epub 2015 Jan 28. No abstract available.

PMID:
25632062
11.

The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab.

Maillet M, Dréanic J, Dhooge M, Mir O, Brezault C, Goldwasser F, Chaussade S, Coriat R.

Anticancer Drugs. 2014 Nov;25(10):1215-9. doi: 10.1097/CAD.0000000000000129.

PMID:
24858536
12.

[Gastric signet ring cell adenocarcinoma: A distinct entity].

Tabouret T, Dhooge M, Rouquette A, Brezault C, Beuvon F, Chaussade S, Coriat R.

Presse Med. 2014 Apr;43(4 Pt 1):353-7. doi: 10.1016/j.lpm.2013.07.024. Epub 2014 Jan 17. Review. French.

PMID:
24440764
13.

A prognostic indicator of survival in metastatic colorectal cancer patients in the era of molecular-targeted agents: the modified Glasgow Prognostic Score.

Dreanic J, Dhooge M, Brezault C, Mir O, Chaussade S, Coriat R.

Oncology. 2014;86(1):44-5. doi: 10.1159/000356879. Epub 2013 Dec 20. No abstract available.

PMID:
24356426
14.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group..

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
15.

Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies.

Dréanic J, Maillet M, Dhooge M, Mir O, Brezault C, Goldwasser F, Chaussade S, Coriat R.

Med Oncol. 2013;30(3):656. doi: 10.1007/s12032-013-0656-y. Epub 2013 Jul 10.

PMID:
23839775
16.

Sarcoidosis lung nodules in colorectal cancer follow-up: sarcoidosis or not?

Lequoy M, Coriat R, Rouquette A, Mir O, Perkins G, Regnard JF, Brezault C, Chaussade S.

Am J Med. 2013 Jul;126(7):642-5. doi: 10.1016/j.amjmed.2012.12.020.

PMID:
23787197
17.

Blood pressure monitoring in patients receiving bevacizumab.

Coriat R, Dhooge M, Brezault C, Chaussade S, Mir O.

Ann Oncol. 2013 Apr;24(4):1127. doi: 10.1093/annonc/mdt022. Epub 2013 Feb 13. No abstract available.

PMID:
23406735
18.

Cervical extravasation of bevacizumab.

Dréanic J, Coriat R, Mir O, Perkins G, Boudou-Rouquette P, Brezault C, Dhooge M, Goldwasser F, Chaussade S.

Anticancer Drugs. 2013 Apr;24(4):426-8. doi: 10.1097/CAD.0b013e32835cfef1.

PMID:
23262983
19.

Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.

Dhooge M, Coriat R, Mir O, Perkins G, Brezault C, Boudou-Rouquette P, Goldwasser F, Chaussade S.

Oncology. 2013;84(1):32-8. doi: 10.1159/000342763. Epub 2012 Oct 16.

PMID:
23076239
20.

[Neuroendocrine pancreatic tumors and helpfulness of targeted therapies].

Vaysse T, Coriat R, Perkins G, Dhooge M, Brezault C, Chaussade S.

Presse Med. 2013 Jun;42(6 Pt 1):961-7. doi: 10.1016/j.lpm.2012.06.017. Epub 2012 Sep 23. Review. French.

PMID:
23009947

Supplemental Content

Loading ...
Support Center